Target intelligence / Profile preview

DNA polymerase iota (Pol ι (Pol iota))

Target
Pol ι (Pol iota)
Molecular classification
Enzyme, DNA polymerase, Y family DNA polymerase, DNA repair enzyme
01

Overview

DNA polymerase iota is a specialized, low-fidelity enzyme of the Y family of DNA polymerases, encoded by the POLI gene in humans[5][6]. It is primarily involved in translesion synthesis (TLS), allowing DNA replication to occur across damaged templates—including lesions such as abasic sites and pyrimidine dimers—but it is error-prone and prone to specific misincorporations, especially opposite template thymine[2][3][4][6]. Pol ι also participates to a limited extent in base excision repair (BER) and is implicated in the cellular response to oxidative stress, mediating protection against oxidative DNA damage by interacting with other repair factors like XRCC1[3]. Uniquely, loss or deficiency of DNA polymerase iota causes increased replication rate and checkpoint failure, leading to genomic instability, while overexpression has been observed in various tumor types, suggesting a complex role in cancer biology[1][3].

Other names
Pol iotaPOLIhPolιDNA pol iota
02

Mechanism of action

For conceptual or exploratory inhibitors: Inhibition of translesion DNA synthesis or base excision repair activity, increasing cellular sensitivity to DNA-damaging agents

03

Biological functions

Translesion DNA synthesisDNA repair (including base excision repair)DNA damage toleranceCheckpoint activation during DNA replicationResponse to oxidative stress
04

Disease associations

Cancer (overexpressed in some tumors)Genomic instabilityResponse to oxidative DNA damage
05

Safety considerations

Targeting may cause increased genomic instability or hypersensitivity to oxidative DNA damageEssential for balancing DNA replication speed and checkpoint function to avoid aneuploidy and chromosomal aberrations
06

Biomarkers

Overexpression in certain cancers could potentially serve as a biomarkerSensitivity to oxidative DNA damage in cells with reduced Pol ι levels

Beyond the preview

Go deeper on DNA polymerase iota (Pol ι (Pol iota)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA polymerase iota (Pol ι (Pol iota)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call